With the cost of drug development continuing to increase and venture funding in a drought, changes in the works for federal Small Business Innovation Research (SBIR) grants aim to help fill the funding gap.
New rules in the reauthorized SBIR program that include funding increases, along with broader accessibility provisions, are expected to go into effect over the next six months or so and run until 2017, Michael Weingarten, director of the National Cancer Institute’s NCI SBIR Development Center, told a panel at the BIO 2012 convention, running June 18-22 in Boston.
To read the full, original article click on this link: Government broadens SBIR grants - Mass High Tech Business News
